IPO News Archive
Omeros quiet period ends November 16

11/11/09


Omeros, which develops drugs for the treatment of surgery-related inflammation and pain, will see its quiet period end next Monday, Nov. 16. On October 7, 2009, the company raised $68.2 million by offering 6.8 million shares at $10.00, at the low end of the range of $10.00 to $12.00. Deutsche Bank acted as the lead manager on the deal.

View IPO Profile: OMER         
Source: www.RenaissanceCapital.com
Latest User Comments

Attribution Policy: The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital, Greenwich, CT (www.renaissancecapital.com).
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital and/or the IPO Plus Fund (symbol: IPOSX) may have investments in securities of companies mentioned.
Invest in the IPO Plus Fund
About Fund Prospectus Invest